Drug Shortage Report for NAT-DONEPEZIL

Last updated on 2025-04-22 History
Report ID 254178
Drug Identification Number 02439565
Brand name NAT-DONEPEZIL
Common or Proper name DONEPEZIL
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) DONEPEZIL HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-04-11
Actual start date 2025-04-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-04-22 English Compare
v7 2025-04-21 French Compare
v6 2025-04-21 English Compare
v5 2025-04-12 English Compare
v4 2025-04-08 French Compare
v3 2025-04-08 English Compare
v2 2025-04-04 French Compare
v1 2025-04-04 English Compare

Showing 1 to 8 of 8